Capstone Investment Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Capstone Investment Advisors’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-36,400	Closed	-$424K	–	482
2014 Q1	$424K	Buy	+36,400	New	+$616K	0.01%	333

Capstone Investment Advisors's MNTA Position: Q4 2020 in Review

Capstone Investment Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 453,362 shares — an estimated $23.8M sold.

Capstone Investment Advisors first reported a position in MNTA in Q1 2014 and held it in 3 quarters. The position peaked at $23.8M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Capstone Investment Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Capstone Investment Advisors sold 453,362 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $23.8M.
Capstone Investment Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2014 and held it in 3 quarters.
Capstone Investment Advisors's Momenta Pharmaceuticals, Inc. position peaked at $23.8M in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Capstone Investment Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.